Clinical Trial Update: Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 window-of-opportunity study evaluating intraperitoneal TROP2 CAR/IL-15 TGFBR2 KO natural killer (NK) cells for managing gastric cancer with peritoneal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• TROP2 CAR/IL-15 TGFBR2 KO NK cells

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Gastric Cancer, Metastatic | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING